Health Canada Authorizes ANOSMIC COVID-19 Rapid Detection Home Test

TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Virocule Inc. today announced that it has received authorization from Health Canada for the sale of its ANOSMICTMCOVID-19 Smell Tester. ANOSMICTM is the first and only authorized Class 1 medical device that can screen subjects at home on regular basis to control the spread of coronavirus. Sudden loss or deterioration of smell is a common and early symptom of people suffering a COVID-19 infection. Recent studies indicate that over 80% of people have smell disturbances.1
ANOSMICTM is a spray engineered from a combination of ingredients to produce a characteristic odor. The subject inhales and records the intensity of smell on regular basis. If there is sudden loss or deterioration of smell, one is advised to seek medical attention and obtain a confirmatory test (e.g. RT-PCR). Chief Scientific Officer, Dr. Deven Sandhu, said “In clinical studies with 211 participants, ANOSMICTMwas shown to have high accuracy of over 90% in screening for a COVID-19 infection (91% sensitivity and 97% specificity at a 95% confidence interval). Research by others has shown that smell loss is a much more specific indicator of a COVID-19 infection than elevated temperature/fever. The nasal passage is a principal gateway for the coronavirus to enter the body. That may be a reason why loss of smell may be an early indicator of an infection.”Globally the COVID-19 virus has infected over 67 million patients with mortality of over 1.5 million patients in 191 countries. Specially, the COVID-19 virus has infected over 425,000 and caused 12,787 Canadian deaths. Positivity rates and daily cases are surging daily to higher record levels. Currently, tests available for detecting the virus take too long to give results and are expensive (e.g. RT-PCR takes 2-4 days and costs over $200/test). Michael Bryant, President, notes, “In the absence of a practical daily screening system, many businesses have had to shut down or operate with limited staff for fear of triggering “super spreader” events. Millions have lost their jobs and livelihood. With the holidays approaching, there is serious concern that close family and friends may see increased infection rates if they socialize. ANOSMICTMis fast (<30 sec./test), cost-effective (<$0.35/test), accurate (>90%), non-invasive and easy-to-use regularly.”ANOSMIC has also been adopted by ETIO Public Health Consultants in its screening protocol for use in conjunction with its CovidGuardTM service for businesses. Dr. Nitin Mohan, a partner and noted epidemiologist, said “…this test in combination with other screening tools will provide optimal screening coverage, allowing sectors of our societies to regain some level of pre-pandemic normalcy. Taking into account the Swiss cheese model of multi layered prevention in order to reduce virus transmission; the utilization of a rapid screening test is paramount in re-opening our societies in the safest and quickest way possible. As the pandemic continues to harm our economies and expose our most vulnerable communities to hardships that will result in downstream health consequences I feel that this test will provide governments, businesses and individuals the ability to protect themselves, their communities and regain normalcy to their disrupted lives.ANOSMICTM is made in Canada and available for sale immediately on www.Virocule.com and soon from major retailers. Virocule Inc. is a Markham based private company that does research and manufacturing of medical screening devices for a variety of neurological and viral diseases and other health care products.1 Sutherland, Stephanie, “Mysteries of COVID Smell Loss Finally Yield Some Answers,” Scientific American, November 18, 2020
Contact: Michael Bryant
michael.bryant@virocule.com
+1 (705) 340-9880


CBJ Newsmakers

Recommended
Gildan Included in Leadership Band on CDP's 2020 Climate Change ReportGibson Energy Announces $250 Million Hybrid Note Offering